Skin autofluorescence as a marker of tissue AGE accumulation has additional value to the UKPDS risk-score in predicting cardiovascular disease in type 2 diabetes

被引:0
|
作者
Lutgers, H. L.
Gerrits, E. G.
Bilo, H. J.
Smit, A. J.
机构
[1] Univ Groningen, Med Ctr, Groningen, Netherlands
[2] Isala Clin, Ctr Diabet, Zwolle, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0100
引用
收藏
页码:S47 / S48
页数:2
相关论文
共 50 条
  • [1] Skin autofluorescence is additive to the UKPDS risk-score in the prediction of cardiovascular complications in type 2 diabetes
    Lutgers, Helen L.
    Gerrits, Esther G.
    Bilo, Henk J.
    Smit, Andries J.
    [J]. DIABETES, 2007, 56 : A173 - A174
  • [2] Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus
    H. L. Lutgers
    E. G. Gerrits
    R. Graaff
    T. P. Links
    W. J. Sluiter
    R. O. Gans
    H. J. Bilo
    A. J. Smit
    [J]. Diabetologia, 2009, 52
  • [3] Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus
    Lutgers, H. L.
    Gerrits, E. G.
    Graaff, R.
    Links, T. P.
    Sluiter, W. J.
    Gans, R. O.
    Bilo, H. J.
    Smit, A. J.
    [J]. DIABETOLOGIA, 2009, 52 (05) : 789 - 797
  • [4] Comparison of the Framingham Risk Score, SCORE, and UKPDS Risk Engine for Predicting Cardiovascular Disease Complications in People with Diabetes
    Ho, Joyce C.
    Staimez, Lisa R.
    Narayan, K. M. Venkat
    Simpson, Roy L.
    Hertzberg, Vicki S.
    [J]. DIABETES, 2019, 68
  • [5] Follow-up skin autofluorescence as a marker of altered tissue AGE accumulation and oxidative stress in type 2 diabetes mellitus
    Gerrits, E. G.
    Lutgers, H. L.
    Smit, A. J.
    Bilo, H. J. G.
    [J]. DIABETOLOGIA, 2008, 51 : S525 - S526
  • [6] Skin autofluorescence as proxy of tissue AGE accumulation is dissociated from SCORE cardiovascular risk score, and remains so after 3 years
    Tiessen, Ans H.
    Jager, Willemein
    ter Bogt, Nancy C. W.
    Beltman, Frank W.
    van der Meer, Klaas
    Broer, Jan
    Smit, Andries J.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (01) : 121 - 127
  • [7] The validity of the UKPDS risk equation for predicting the likelihood of cardiovascular heart disease events in Type 2 diabetes
    McEwan, P
    Bagust, A
    Hopkinson, P
    Peters, JR
    Currie, CJ
    [J]. DIABETOLOGIA, 2001, 44 : A253 - A253
  • [8] Skin Autofluorescence as a Potential Adjunctive Marker for Cardiovascular Risk Assessment in Type 2 Diabetes: A Systematic Review
    Reurean-Pintilei, Delia
    Pantea Stoian, Anca
    Potcovaru, Claudia-Gabriela
    Salmen, Teodor
    Cinteza, Delia
    Stoica, Roxana-Adriana
    Lazar, Sandra
    Timar, Bogdan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [9] Estimating Cardiovascular Risk in People with Type 2 Diabetes and Cardiovascular Disease: UKPDS Outcomes Model
    Coleman, Ruth L.
    Gray, Alastair M.
    Mcguire, Darren K.
    Holman, Rury R.
    [J]. DIABETES, 2019, 68
  • [10] Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
    Coleman, R. L.
    Stevens, R. J.
    Holman, R. R.
    [J]. DIABETIC MEDICINE, 2007, 24 : 56 - 56